Benutzer: Gast  Login
Titel:

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma.

Dokumenttyp:
Clinical Trial; Clinical Trial, Phase II; Journal Article; Article
Autor(en):
Reichardt, P; Oechsle, K; Pink, D; Bokemeyer, C; Schneller, F; Issels, R; Kanz, L; Hartmann, JT
Abstract:
BACKGROUND: The number of effective cytotoxic agents for the treatment of patients with metastatic soft tissue sarcoma (STS) is limited, especially when patients have failed anthracyline-based chemotherapy. PATIENTS AND METHODS: Between 1999 and 2000 a total of 16 patients with histologically proven STS progressing during or after first-line anthracycline-based chemotherapy were entered into this open-label, noncomparative study. Topotecan was administered as a 30-min infusion at a dosage of 1.5...     »
Zeitschriftentitel:
Invest New Drugs
Jahr:
2003
Band / Volume:
21
Heft / Issue:
4
Seitenangaben Beitrag:
481-6
Sprache:
eng
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/14586217
Print-ISSN:
0167-6997
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX